Pharmacy Report Archives - Page 52 of 150 - Becker's Hospital Review

6 Ozempic updates | Medical supply scam could cost US $2B | 1st severe frostbite drug approved | Pa. physician sentenced in patient death | 6 promising cancer vaccines

February 14, 2024 BHR Newsletter 1. Alleged Medicare catheter billing scam could cost $2B Full story 2. FDA approves 1st treatment for severe frostbite Full story 3. 6 Ozempic updates Full story 4. Some hospitals struck a balancing act in…

CDC to scale Mich. system's pharmacy program | Aspiring pharmacist union rebukes CVS' profits | Dallas system, Pfizer partner | 12 hospitals cutting jobs

February 13, 2024 BHR Newsletter 1. CDC seeks to expand U of Michigan's hypertension pharmacy program model Full story 2. UT Southwestern partners with Pfizer on RNA delivery tech Full story 3. Aspiring pharmacist union slams CVS' $2B earnings Full…

Gyms reply to Ozempic side effect | Phenylephrine's popularity problem | 10 most lucrative healthcare cos. | Pharmacy leaders admit to $65M scheme | A cancer drug that may treat Parkinson's

February 12, 2024 BHR Newsletter 1. Gyms, nutrition startups race to combat Ozempic muscle loss Full story 2. If FDA swipes common decongestant, supply issues expected Full story 3. Sutter hospital employee stabbed, man charged Full story 4. Adventist Health deconstructed the…

Kaiser's pharmacy cuts emissions | 10 systems seeking pharmacy leaders | A 4-day workweek in healthcare | Mercy hospital to move pharmacy

February 8, 2024 BHR Newsletter 1. Kaiser's playbook for slashing carbon emissions Full story 2. Joint Commission's authority to accredit home infusion therapy services renewed Full story 3. Weight loss drugs tied to fewer anxiety, depression cases: Study Full story…

Top 20 schools by 1st-time NAPLEX pass rates | Zepbound succeeds in liver disease trial | Drug shortages cost hospitals $550M: AHA | Amazon cuts pharmacy jobs | 2 cancer vaccine candidates

February 7, 2024 BHR Newsletter 1. Top 20 pharmacy schools for first-time NAPLEX pass rates Full story 2. Zepbound, Mounjaro show potential for fatty liver disease Full story 3. Amazon cuts jobs in pharmacy, other healthcare divisions Full story 4.…

5 Ozempic updates | 2 more cancer drug shortages | Novo Nordisk buys 3 fill-finish sites | J&J accused of mismanaging drug benefits | Yale New Haven opens 4th pharmacy

February 6, 2024 BHR Newsletter 1. 5 Ozempic updates Full story 2. FDA to consider RSV vaccine for adults in their 50s Full story 3. 2 more cancer drug injectables fall into shortage Full story 4. Hartford HealthCare treats 6K new cancer…

Blood pressure drops in Zepbound study | Walgreens, pharmacy schools partner | ASHP taps 5 leaders to new committee | 'Obesity bill of rights' drafted | Rush lays off leaders

February 5, 2024 BHR Newsletter 1. Zepbound may significantly lower blood pressure in overweight adults, new study finds Full story 2. What an 'obesity bill of rights' means for medical care amid the rise of weight loss drugs Full story 3.…

Top 15 schools by NAPLEX pass rates | Penicillin rationed | MemorialCare layoffs extend past pharmacy | Mix-up spurs ADHD pill recall | 10 systems seeking pharmacy leaders

February 1, 2024 BHR Newsletter 1. Clinicians ration penicillin amid syphilis surge Full story 2. Meet the 24-year-old running a Colorado hospital Full story 3. Top 15 pharmacy schools by NAPLEX pass rates Full story 4. Are you a pharmacy…

9 new drug shortages | Aduhelm pulled | Mich. system sharpens specialty pharmacy goals | Walgreens lays off more corporate staff | No. 1 issue for hospital CEOs

January 31, 2024 BHR Newsletter 1. Michigan Medicine makes specialty pharmacy a strategic focus Full story 2. 9 drugs now in shortage Full story 3. Biogen abandons controversial Alzheimer's drug Aduhelm Full story 4. Are you a CMO, CNO or CMIO…

Baptist's $40M pharmacy to open in June | Contaminated drugs tied to Alzheimer's | Paxlovid EUA nears end | Weight loss meds might be anti-inflammatory

January 30, 2024 BHR Newsletter 1. Baptist Health nears completion of $40M central pharmacy Full story 2. FDA sets end date for Paxlovid emergency use Full story 3. Contaminated injectionables tied to cases of early Alzheimer's Full story 4. Are…